Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II

Fig. 1

Study design. aIn addition to the assessments performed at baseline shown in the figure, the screening period includes: obtaining/evaluating informed consent/assent, inclusion/exclusion criteria, genotyping, demographic information and medical history. bHeight and weight were measured at baseline and at months 12 and 24 only. BSID-III Bayley Scales of Infant Development, third edition; DAS-II Differential Ability Scales, second edition; EQ-5D five-dimension EuroQol questionnaire; HRQoL health-related quality of life; HS-FOCUS Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale; VABS-II Vineland Adaptive Behavior Scales, second edition

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172